175 related articles for article (PubMed ID: 29510777)
1. lncRNA FEZF1-AS1 Is Associated With Prognosis in Lung Adenocarcinoma and Promotes Cell Proliferation, Migration, and Invasion.
Liu Z; Zhao P; Han Y; Lu S
Oncol Res; 2018 Dec; 27(1):39-45. PubMed ID: 29510777
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA FEZF1-AS1 facilitates cell proliferation and migration in colorectal carcinoma.
Chen N; Guo D; Xu Q; Yang M; Wang D; Peng M; Ding Y; Wang S; Zhou J
Oncotarget; 2016 Mar; 7(10):11271-83. PubMed ID: 26848625
[TBL] [Abstract][Full Text] [Related]
3. The lncRNA FEZF1-AS1 Promotes the Progression of Colorectal Cancer Through Regulating OTX1 and Targeting miR-30a-5p.
Li J; Zhao LM; Zhang C; Li M; Gao B; Hu XH; Cao J; Wang GY
Oncol Res; 2020 Feb; 28(1):51-63. PubMed ID: 31270006
[TBL] [Abstract][Full Text] [Related]
4. LncRNA TP73-AS1 promoted the progression of lung adenocarcinoma via PI3K/AKT pathway.
Liu C; Ren L; Deng J; Wang S
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30541897
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA FEZF1-AS1 promotes rectal cancer progression by competitively binding miR-632 with FAM83A.
Xie R; Liu C; Liu L; Lu X; Tang G
Acta Biochim Biophys Sin (Shanghai); 2022 Apr; 54(4):452-462. PubMed ID: 35607960
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA FEZF1-AS1 promotes breast cancer stemness and tumorigenesis via targeting miR-30a/Nanog axis.
Zhang Z; Sun L; Zhang Y; Lu G; Li Y; Wei Z
J Cell Physiol; 2018 Nov; 233(11):8630-8638. PubMed ID: 29797562
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA FEZF1-AS1 indicates a poor prognosis of gastric cancer and promotes tumorigenesis via activation of Wnt signaling pathway.
Wu X; Zhang P; Zhu H; Li S; Chen X; Shi L
Biomed Pharmacother; 2017 Dec; 96():1103-1108. PubMed ID: 29239821
[TBL] [Abstract][Full Text] [Related]
8. FEZF1-AS1: a novel vital oncogenic lncRNA in multiple human malignancies.
Shi C; Sun L; Song Y
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31175144
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA FEZF1-AS1 in human cancers.
Zhou Y; Xu S; Xia H; Gao Z; Huang R; Tang E; Jiang X
Clin Chim Acta; 2019 Oct; 497():20-26. PubMed ID: 31276636
[TBL] [Abstract][Full Text] [Related]
10. FEZF1-AS1 is a key regulator of cell cycle, epithelial-mesenchymal transition and Wnt/β-catenin signaling in nasopharyngeal carcinoma cells.
Cheng Y
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30355645
[TBL] [Abstract][Full Text] [Related]
11. [Role of lncRNA Fez family zinc finger protein 1 antisense RNA1 in hepatocellular carcinoma].
Yao J; Wang XP; Zhang ZZ; Yang J; Yang Z; Qian HX
Zhonghua Zhong Liu Za Zhi; 2019 Sep; 41(9):667-674. PubMed ID: 31550856
[No Abstract] [Full Text] [Related]
12. Long Noncoding RNA FEZF1-AS1 Promotes Proliferation and Inhibits Apoptosis in Ovarian Cancer by Activation of JAK-STAT3 Pathway.
Zhao X; Cheng Z; Wang J
Med Sci Monit; 2018 Nov; 24():8088-8095. PubMed ID: 30416194
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of lncRNA FEZF1 antisense RNA 1 over-expression in oncologic outcomes of patients with solid tumors.
Zhang Y; Yang QX; Peng TT; Wang LJ; Xiao GL; Tang SB
Medicine (Baltimore); 2019 Jun; 98(24):e15982. PubMed ID: 31192939
[TBL] [Abstract][Full Text] [Related]
14. LncRNA TTN-AS1 promotes migration, invasion, and epithelial mesenchymal transition of lung adenocarcinoma via sponging miR-142-5p to regulate CDK5.
Jia Y; Duan Y; Liu T; Wang X; Lv W; Wang M; Wang J; Liu L
Cell Death Dis; 2019 Jul; 10(8):573. PubMed ID: 31363080
[TBL] [Abstract][Full Text] [Related]
15. LncRNA-FEZF1-AS1 Promotes Tumor Proliferation and Metastasis in Colorectal Cancer by Regulating PKM2 Signaling.
Bian Z; Zhang J; Li M; Feng Y; Wang X; Zhang J; Yao S; Jin G; Du J; Han W; Yin Y; Huang S; Fei B; Zou J; Huang Z
Clin Cancer Res; 2018 Oct; 24(19):4808-4819. PubMed ID: 29914894
[No Abstract] [Full Text] [Related]
16. LncRNA FEZF1-AS1 Modulates Cancer Stem Cell Properties of Human Gastric Cancer Through miR-363-3p/HMGA2.
Hui Y; Yang Y; Li D; Wang J; Di M; Zhang S; Wang S
Cell Transplant; 2020; 29():963689720925059. PubMed ID: 32638620
[TBL] [Abstract][Full Text] [Related]
17. LncRNA ZFPM2-AS1 promotes lung adenocarcinoma progression by interacting with UPF1 to destabilize ZFPM2.
Han S; Cao D; Sha J; Zhu X; Chen D
Mol Oncol; 2020 May; 14(5):1074-1088. PubMed ID: 31919993
[TBL] [Abstract][Full Text] [Related]
18. LncRNA FEZF1-AS1 enhances epithelial-mesenchymal transition (EMT) through suppressing E-cadherin and regulating WNT pathway in non-small cell lung cancer (NSCLC).
He R; Zhang FH; Shen N
Biomed Pharmacother; 2017 Nov; 95():331-338. PubMed ID: 28858731
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding antisense RNA FAM83A-AS1 promotes lung cancer cell progression by increasing FAM83A.
Shi R; Jiao Z; Yu A; Wang T
J Cell Biochem; 2019 Jun; 120(6):10505-10512. PubMed ID: 30659636
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA FEZF1-AS1 promotes cell invasion and epithelial-mesenchymal transition through JAK2/STAT3 signaling pathway in human hepatocellular carcinoma.
Wang YD; Sun XJ; Yin JJ; Yin M; Wang W; Nie ZQ; Xu J
Biomed Pharmacother; 2018 Oct; 106():134-141. PubMed ID: 29957463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
